Description
Background:
Vopratelimab is an investigational monoclonal antibody that targets an immune checkpoint protein called TIM-3 (T-cell immunoglobulin and mucin-domain containing-3). TIM-3 is expressed on the surface of certain immune cells, including T cells, and plays a role in regulating immune responses. By binding to TIM-3, vopratelimab aims to modulate the immune system and potentially enhance anti-tumor immune responses. It is being studied as a potential immunotherapy for various types of cancer, including solid tumors and hematological malignancies.
Intended Use:
For Estimation of Vopratelimab in human serum and plasma. Please note the kit has not been optimized to be used for any other animal species. Should you require a specific sera tested, please connect with us at sales@krishgen.com for optimization.
If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!